2018 U.S.-Booked Air Volume: $54 million
2018 Global Air Volume: $91 million
2018 U.S. T&E: $121 million
2018 Global T&E: $168 million
Primary Air Suppliers: United, Delta, American
Primary Hotel Suppliers: Marriott, Hilton, Intercontinental
Primary Car Rental Supplier: Hertz
Primary Global Online Booking Tool: Concur
Primary U.S. Payment Supplier: Bank of America
Card Program: individual bill, central pay
Primary U.S. Expense Supplier: Concur
Primary Global Travel Risk Management Supplier: WorldAware
Consolidated Global TMC: Amex GBT
Biotech firm Thermo Fisher Scientific generated $24 billion in worldwide revenue in 2018, and company growth, fueled in part by strategic acquisitions, has been reflected in rising U.S.-point-of-sale air bookings, from $45 million in 2017 to $54 million in 2018 and a projected $60 million on 2019. Eighty percent of U.S.-booked air volume in 2018 was for domestic travel. The company has a single consolidated global travel policy. Only 51 percent of U.S.-booked tickets went through approved online tools in 2018, and 51 percent of those required agent assistance. That should improve in 2019, however, as Thermo Fisher Scientific looks to expand American Express Global Business Travel to more of its acquired subsidiaries, as well as to countries where it has smaller employee populations. It's also introducing Amex GBT's Air Re-shop this year, and the company is considering changes to its meal allowance policy.